Key CMC Considerations For Mrna Therapeutics Towards Ind Approval
- Deciphering end-to-end mRNA therapeutic workflows that underpin CMC readiness for IND
- Prioritizing key CMC considerations across materials, process development, and controls for IND submission
- Showcasing CATUG Biotechnology’s one-stop CMC service to streamline development toward filing